> Products > CAS:439239-92-6

China CAS:439239-92-6 Manufacturer

We insist over the principle of enhancement of 'High high quality, Efficiency, Sincerity and Down-to-earth working approach' to offer you with superb assistance of processing for CAS:439239-92-6, Top quality, timely company and Aggressive cost, all win us a superior fame in xxx field despite the international intense competition.
CAS:439239-92-6, Our company has a skillful sales team, strong economic foundation, great technical force, advanced equipment, complete testing means, and excellent after-sales services. Our goods have beautiful appearance, fine workmanship and superior quality and win the unanimous approvals of the customers all over the world.

Hot Products

Cyproterone Acetate
For Cyproterone Acetate (CPA), we have CP and EP specifications, CEP/TGA/EU-GMP available.
CAS:427-51-0
Tibolone
Tibolone complies with EP specification. DMF is approved.
CAS:5630-53-5
21-acetoxy-11β-hydroxypregna-1,4,16-triene-3,20-dione
21-Acetoxy-11β-hydroxypregna-1,4,16-triene-3,20-dione is an intermediate in the synthesis of Budesonide (B689490) related derivatives.
CAS:3044-42-6
DHEA Acetate(Prasterone Acetate)
DHEA Acetate(Prasterone Acetate) is the intermediate of DHEA(prasterone).
CAS:853-23-6
16alpha-Hydroxyprednisolone Acetate
16alpha-Hydroxyprednisolone Acetate is used to observe interaction of some steroid drugs with β-cyclodextrin polymer to calculate the relative strengh of interaction between the hydrophobicity parameters of the drugs and the strenght of the drug-β-cyclodextrin polymer.
CAS:86401-80-1
4-aza-5α-androstan-3-oxo-17β-carboxylic acid
4-aza-5α-androstan-3-oxo-17β-carboxylic acid is an intermediate of Dutasteride.
CAS:104239-97-6

Related Blog
Reviews

2019 CPhI China Exhibition Shanghai
June 2019
CPhI is the undisputed leader in the pharmaceutical industry. CPhI China offers a key access point to the second largest pharma market in the world. The exhibition features over 3,000 companies and incorporates various API showcases like bioLIVE, iCSE, NEX and FDF, creating a comprehensive platform that connects the entire pharmaceutical industry chain in the Asian-Pacific region.
2022 API Exhibition Qingdao
August 2022
Founded by China National Medical Control Bureau (the predecessor of NPMA) in 1968.
Gathering 97% of Top 100 Chinese pharmaceutical enterprises.
99% manufactures meets the requirements of GMP.
Supported by numerous powerful associations in China: CCFDIE, CPIA, CBPIA, CATCM, CNMA, CNPPA, etc.
2023 See us at DCAT Week, CPHI and API exhibition!
Visit us at Milan CPHI - Booth 3A65!
We're looking forward to welcoming you!
Can 4-aza-5α-androstan-1-ene-3-oxo-17β-carboxylic Acid Become the Preferred Intermediate for Modern Pharmaceutical Research
As pharmaceutical innovation continues to advance, the demand for highly pure steroid intermediates has increased significantly. Among these compounds, 4-aza-5α-androstan-1-ene-3-oxo-17β-carboxylic acid has attracted considerable attention due to its unique molecular structure, stability, and importance in the synthesis of several biologically active steroid derivatives.
Why Is Estradiol Valerate a Key Estrogen API in Hormone Therapy?
Discover why Estradiol Valerate is a key estrogen API in hormone therapy. Technical analysis of its pharmacological profile, manufacturing standards, and clinical applications.

China CAS:439239-92-6 Manufacturer

Related Products

Hot Products

Cyproterone Acetate

CAS:427-51-0

Tibolone

CAS:5630-53-5

21-acetoxy-11β-hydroxypregna-1,4,16-triene-3,20-dione

CAS:3044-42-6

DHEA Acetate(Prasterone Acetate)

CAS:853-23-6

16alpha-Hydroxyprednisolone Acetate

CAS:86401-80-1

4-aza-5α-androstan-3-oxo-17β-carboxylic acid

CAS:104239-97-6

2019 CPhI China Exhibition Shanghai

2022 API Exhibition Qingdao

2023 See us at DCAT Week, CPHI and API exhibition!

Visit us at Milan CPHI - Booth 3A65!

Can 4-aza-5α-androstan-1-ene-3-oxo-17β-carboxylic Acid Become the Preferred Intermediate for Modern Pharmaceutical Research

Why Is Estradiol Valerate a Key Estrogen API in Hormone Therapy?

Alberta 2024-01-08 04:08:09

Belle 2022-08-30 13:49:57

Geraldine 2022-12-25 06:51:20

Sara 2024-04-21 03:54:47

mary rash 2022-12-07 00:55:10

Maureen 2022-09-09 18:25:18

Send Inquiry